Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

Cairo University (CU)

Status

Not yet enrolling

Conditions

Pulpitis - Irreversible

Treatments

Procedure: Endoflas pulpectomy

Procedure: NeoPUTTY MTA pulpotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT06922578

Neoputty MTA pulpotomy

Details and patient eligibility

About

The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis.

The main question it aims to answer is:

Will Neoputty MTA pulpotomy have higher clinical and radiographic success in comparison to Endoflas pulpectomy in primary molars with irreversible pulpitis?

Enrollment

66 estimated patients

Sex

All

Ages

4 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Children with spontaneous pain lasting a few seconds to several hours.
Pain is intensified by thermal stimulus and persists after its removal.
Pulp hemorrhage after performing access cavity and deroofing of pulp chamber showing reddish pink healthy pulp tissue.
Radicular pulp health is verified by achieving hemostasis within six minutes of compression using a cotton pellet with 2% sodium hypochlorite.
Absence of peri-apical or inter-radicular radiolucency, widening of periodontal ligament space, internal or external root resorption.

Exclusion criteria